Close
Patheon

Articles & White Papers

Biologics

Small Molecule API

Product Development

  • Author: Marshall Crew, Ph.D.
    The Biopharmaceutics Classification System (BCS), developed by the U.S. Food and Drug Administration to simplify and accelerate the drug development process, helps companies when they file for bioequivalence of dosage forms based on in vitro dissolution testing....View More

    more...
  • Author: Tim Wright
    Kaspar van den Dries, director, research & development, Europe at Patheon, is featured in an article on solid dosage outsourcing trends published in Contract Pharma. The market continues to evolve as blockbusters are replaced by more targeted treatments that have unique requirements. ...View More

  • Author: Matthew Knopp
    Eric Jayjock, director of continuous manufacturing at Patheon, and Kaspar van den Dries, senior director, formulation sciences, solid dose and softgels at Patheon, discussed outsourcing, mergers and acquisitions, expansion plans and continuous manufacturing in an article published by Tablets & Capsules. ...View More

  • Author: Susan Birks
    Marshall Crew, vice president of global PDS scientific excellence at Patheon, discusses the latest trends driving developments in ingredients, in an article by Susan Birks, published in Manufacturing Chemist. ...View More

  • The proportion of poorly soluble drug compounds in the development pipeline is on the rise, with 70% to 90% of current pipeline drugs falling in the two low-solubility classes of the Biopharmaceutical Classification System. With the emergence of new techniques to improve solubility, low solubility compounds are more likely to advance to the clinic. ...View More

  • Franco Negron, senior vice president, North America commercial operations and global integration at Patheon, discussed how the relationship between sponsors and contract manufacturing organizations have evolved into being more strategic and solutions-oriented in an article "Evolving CMO-Sponsor Relationships" published by Genetic Engineering & Biotechnology News. ...View More

  • BOM Foreign Investments article "Patheon fosters innovation and delivers industry-leading service in Brabant" features Patheon's Tilburg plant that specializes in the development and manufacture of ‘softgels’- capsules containing liquid doses of medicines and nutritional supplements. The company’s local clients include household names such as Pfizer, Perrigo and Reckitt Benckiser....View More

  • 'Pharmaceutical Technology' features an article "Black Specks in Tablet Stability Samples" by Geoff Carr, director of analytical development at Patheon....View More

Commercial Product Supply

  • Author: Jennifer Markarian
    An article in the Pharmaceutical Technology magazine describes how transferring the manufacturing of a drug from one scale to another or between manufacturing sites presents both technical and business challenges....View More

  • Author: Suzanne Shelley
    'Pharmaceutical Commerce' magazine features an article "Pediatric drug market finds its own pathway" by Suzanne Shelley. Even with legislative incentives, pharma manufacturers struggle to cost-justify pediatric innovation. Anil Kane, executive director, global formulation sciences, PDS at Patheon, speaks about the growth in the global pediatric drug market....View More

  • Author: Frank Vinluan
    Frank Vinluan writes in an article "Patheon's Mullen: Drug Price Debate Could Shape Pharma's Future," published in Xconomy: "Even as Patheon CEO Jim Mullen sees promise in the scientific advances made in drug development, he says many of the pharmaceutical industry’s challenges ahead are economic."...View More

  • Author: James Mullen
    James Mullen, CEO of Patheon, discusses the demands of pharma forecasting in an article "Does Demand Forecasting Keep You Awake at Night?" published by Life Science Leader....View More

  • Author: Fiona Barry
    In an article "CMO use on the up, low margins ahead" published by 'Outsourcing Pharma', Fiona Barry writes about the rise of Contract manufacturing over the next five years as drugmakers feel the pressure to reduce supply chain time....View More

  • Author: Franco Negron
    Franco Negron, senior vice president of the CMO business for North America at Patheon offers his take on where pharmaceutical outsourcing is heading in the next decade in an article "The state of the pharmaceutical outsourcing market" published by 'Speciality Chemicals Magazine'. ...View More

  • Author: Anil Kane, Ph.D., MBA
    Anil Kane, Ph.D., executive director, global head of formulations, pharmaceutical development services at Patheon, commented on the future of CDMOs and in-house API capabilities when participating in Drug Development & Delivery’s global formulation report. ...View More

  • Author: Franco Negron
    Franco Negron, senior vice president, drug product services, North America at Patheon, was featured in an executive interview discussing the company’s comprehensive development and manufacturing solutions, published in 'Drug Development & Delivery'. ...View More

Supply Chain Management

  • Author: Lukas Utiger and Mike Mencer
    The pharmaceutical industry lags in the sophistication and performance of its supply chains when they are compared with best-in-class companies in other industries. This is due to the complexity that has come with new drugs, more complex production technologies and evolving regulatory requirements....View More

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com

 
 

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com